Is Acutus Medical Inc (AFIB) Stock About to Get Hot Friday?

Overall market sentiment has been neutral on Acutus Medical Inc (AFIB) stock lately. AFIB receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.

Acutus Medical Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on AFIB!

See Full AFIB Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With AFIB Stock Today?

Acutus Medical Inc (AFIB) stock is trading at $1.51 as of 2:11 PM on Friday, Jul 29, a rise of $0.07, or 4.78% from the previous closing price of $1.44. The stock has traded between $1.36 and $1.59 so far today. Volume today is less active than usual. So far 217,632 shares have traded compared to average volume of 6,866,646 shares.

More About Acutus Medical Inc

Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Europe. Click Here to get the full Stock Report for Acutus Medical Inc stock.